Artificial Intelligence for Multiple Sclerosis Management Using Retinal Images: Pearl, Peaks, and Pitfalls
Shadi Farabi Maleki,Milad Yousefi,Sayeh Afshar,Siamak Pedrammehr,Chee Peng Lim,Ali Jafarizadeh,Houshyar Asadi,Shadi Farabi MalekiMilad YousefiSayeh AfsharSiamak PedrammehrChee Peng LimAli JafarizadehHoushyar Asadia Nikookari Eye Center,Tabriz University of Medical Sciences,Tabriz,Iranb Faculty of Mathematics,Statistics and Computer Sciences,University of Tabriz,Tabriz,Iranc Faculty of Design,Tabriz Islamic Art University,Tabriz,Irand Institute for Intelligent Systems Research and Innovation (IISRI),Deakin University,Burwood,Australia
DOI: https://doi.org/10.1080/08820538.2023.2293030
2023-12-14
Seminars in Ophthalmology
Abstract:Multiple sclerosis (MS) is a complex autoimmune disease characterized by inflammatory processes, demyelination, neurodegeneration, and axonal damage within the central nervous system (CNS). Retinal imaging, particularly Optical coherence tomography (OCT), has emerged as a crucial tool for investigating MS-related retinal injury. The integration of artificial intelligence(AI) has shown promise in enhancing OCT analysis for MS. Researchers are actively utilizing AI algorithms to accurately detect and classify MS-related abnormalities, leading to improved efficiency in diagnosis, monitoring, and personalized treatment planning. The prognostic value of AI in predicting MS disease progression has garnered substantial attention. Machine learning (ML) and deep learning (DL) algorithms can analyze longitudinal OCT data to forecast the course of the disease, providing critical information for personalized treatment planning and improved patient outcomes. Early detection of high-risk patients allows for targeted interventions to mitigate disability progression effectively. As such, AI-driven approaches yielded remarkable abilities in classifying distinct MS subtypes based on retinal features, aiding in disease characterization and guiding tailored therapeutic strategies. Additionally, these algorithms have enhanced the accuracy and efficiency of OCT image segmentation, streamlined diagnostic processes, and reduced human error. This study reviews the current research studies on the integration of AI,including ML and DL algorithms, with OCT in the context of MS. It examines the advancements, challenges, potential prospects, and ethical concerns of AI-powered techniques in enhancing MS diagnosis, monitoring disease progression, revolutionizing patient care, the development of patient screening tools, and supported clinical decision-making based on OCT images.
ophthalmology